Morgan Stanley’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-287,620
| Closed | -$1.15M | – | 6899 |
|
|
2019
Q4 | $1.15M | Sell |
287,620
-11,523
| -4% | -$54.1K | ﹤0.01% | 4447 |
|
|
2019
Q3 | $1.47M | Sell |
299,143
-1,825
| -0.6% | -$10.2K | ﹤0.01% | 4051 |
|
|
2019
Q2 | $1.83M | Sell |
300,968
-29,165
| -9% | -$155K | ﹤0.01% | 3844 |
|
|
2019
Q1 | $1.92M | Buy |
330,133
+225,099
| +214% | +$2.32M | ﹤0.01% | 3619 |
|
|
2018
Q4 | $1.41M | Buy |
105,034
+1,918
| +2% | +$32.3K | ﹤0.01% | 4038 |
|
|
2018
Q3 | $2M | Sell |
103,116
-31,474
| -23% | -$670K | ﹤0.01% | 3998 |
|
|
2018
Q2 | $3.44M | Sell |
134,590
-47,509
| -26% | -$1.11M | ﹤0.01% | 3576 |
|
|
2018
Q1 | $3.67M | Sell |
182,099
-194,067
| -52% | -$4.53M | ﹤0.01% | 3378 |
|
|
2017
Q4 | $7.55M | Buy |
376,166
+296,461
| +372% | +$5.83M | ﹤0.01% | 2676 |
|
|
2017
Q3 | $1.65M | Sell |
79,705
-237,410
| -75% | -$4.01M | ﹤0.01% | 4047 |
|
|
2017
Q2 | $4.69M | Buy |
317,115
+164,523
| +108% | +$2.74M | ﹤0.01% | 2912 |
|
|
2017
Q1 | $2.43M | Sell |
152,592
-406,719
| -73% | -$5.87M | ﹤0.01% | 3633 |
|
|
2016
Q4 | $7.05M | Buy |
559,311
+462,012
| +475% | +$8.61M | ﹤0.01% | 2635 |
|
|
2016
Q3 | $2.73M | Buy |
97,299
+46,636
| +92% | +$1.56M | ﹤0.01% | 3236 |
|
|
2016
Q2 | $1.77M | Sell |
50,663
-10,039
| -17% | -$316K | ﹤0.01% | 3517 |
|
|
2016
Q1 | $1.66M | Sell |
60,702
-33,324
| -35% | -$981K | ﹤0.01% | 3498 |
|
|
2015
Q4 | $3.22M | Sell |
94,026
-153,943
| -62% | -$4.8M | ﹤0.01% | 3083 |
|
|
2015
Q3 | $7.13M | Sell |
247,969
-31,612
| -11% | -$1.35M | ﹤0.01% | 2305 |
|
|
2015
Q2 | $12.5M | Buy |
279,581
+150,927
| +117% | +$5.68M | ﹤0.01% | 1891 |
|
|
2015
Q1 | $4.45M | Buy |
128,654
+77,256
| +150% | +$2.1M | ﹤0.01% | 2866 |
|
|
2014
Q4 | $1.41M | Buy |
+51,398
| New | +$1.25M | ﹤0.01% | 3864 |
|
Other funds holding DPLO
Morgan Stanley's DPLO Position: Q1 2020 in Review
Morgan Stanley sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 287,620 shares — an estimated $1.15M sold.
Morgan Stanley first reported a position in DPLO in Q4 2014 and held it in 21 quarters. The position peaked at $12.5M in Q2 2015. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- Morgan Stanley reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- Morgan Stanley sold 287,620 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $1.15M.
- Morgan Stanley first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 21 quarters.
- Morgan Stanley's DIPLOMAT PHARMACY, INC. position peaked at $12.5M in Q2 2015.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on Morgan Stanley's 13F filing for Q1 2020, filed 15 May 2020.